News Focus
News Focus
Followers 43
Posts 5340
Boards Moderated 0
Alias Born 12/05/2021

Re: Poor Man - post# 559161

Friday, 01/13/2023 12:51:05 PM

Friday, January 13, 2023 12:51:05 PM

Post# of 822557

Yes, the MAA only requires the MIA for the manual “artesian” manufacturing. But that’s a very expensive process that impact valuations.


Sure there is a difference in valuation. There is also a difference in the valuation of Space X now and Space X after it invented and equipped its rockets with nuclear thermal propulsion. Whats is your point? Seriously I don't get it. There is always a bigger better technology invention thing. Flaskworks is certainly NOT blocking MIA. NICE appraisal and MHRA will accept that this for now is a more expensive treatment than it perhaps may become in the future after Flaskworks works flawlessly.

That in fact could be the sticking point around what the consideration would be for a partnership

Seriously not. Big Pharma is only interested in 2 things when partnering with small bios A How likely is it the drug will be approved/is it approved? B how big is the addressable market? Aka how much revenue can we make to increase our profit per share?

Let me make a suggestion if you permit me. I think you will have to come to terms with the fact that your prediction of a BO/JA after JA/TLD has not come to pass, has nothing todo with Flaskworks or some tech not being ready. Its simple that BP rather prefers to pay x20 more for NWBO after they are FDA (and EMA/UK) approved for production and marketing, then they partner now with the strange duck "will they be approved yes or no called"-NWBO. Because NWBO is a strange duck.

Thats reality
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News